SCHEMBL1633571

SCHEMBL1633571

Brc1ccc(OC2CCNCC2)c2nc(Nc3cccc(N4CCOCC4)c3)ncc12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBK1 Q9UHD2 7/20 0.54
JAK2 O60674 5/20 0.54
SYK P43405 2/20 0.49
CDK2 P24941 3/20 0.48
CCNE1 P24864 2/20 0.48
CCNT1 O60563 2/20 0.48
CDK9 P50750 2/20 0.48
RIPK2 O43353 2/20 0.47
JAK1 P23458 1/20 0.47
TYK2 P29597 1/20 0.47
JAK3 P52333 1/20 0.47
HDAC3 O15379 1/20 0.47
HDAC1 Q13547 1/20 0.47
HDAC2 Q92769 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47
IGF1R P08069 2/20 0.43
CDK1 P06493 1/20 0.42
CDK4 P11802 1/20 0.42
CCNB1 P14635 1/20 0.42
CCND1 P24385 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1633643 0.91 CDK4 (0.51) TBK1JAK2SYKCDK2CCNE1
SCHEMBL1633182 0.90 JAK2 (0.54) TBK1JAK2SYKCDK2CCNE1
SCHEMBL1633613 0.87 JAK2 (0.61) TBK1JAK2SYKCDK2CCNE1
SCHEMBL1633537 0.86 SYK (0.50) TBK1JAK2SYKCDK2CCNE1
SCHEMBL1633103 0.86 JAK2 (0.44) TBK1JAK2SYKCDK2CCNT1
SCHEMBL1633150 0.85 CDK4 (0.52) TBK1JAK2SYKCDK2CCNE1
SCHEMBL1633288 0.84 CDK4 (0.54) TBK1JAK2CDK2CCNE1JAK1
SCHEMBL1633919 0.83 JAK2 (0.50) TBK1JAK2SYKJAK1TYK2
SCHEMBL13498236 0.82 CDK4 (0.51) TBK1JAK2SYKCDK2CCNE1
SCHEMBL13498315 0.82 JAK2 (0.51) TBK1JAK2CDK2CCNE1CCNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 US disclosed